SCHEMBL21032124

SCHEMBL21032124

CCc1ccc(-n2cccn2)c(C(F)(F)F)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
PKM P14618 1/20 0.39
KDM4E B2RXH2 2/20 0.39
ALDH1A1 P00352 2/20 0.39
LMNA P02545 2/20 0.39
GAA P10253 1/20 0.39
G6PD P11413 1/20 0.39
HSD11B1 P28845 2/20 0.37
CRHR1 P34998 1/20 0.37
NPC1 O15118 1/20 0.36
MAPK1 P28482 1/20 0.36
KCNN4 O15554 1/20 0.34
KCNA5 P22460 1/20 0.34
HPGD P15428 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
NOTUM Q6P988 1/20 0.33
BRS3 P32247 1/20 0.33
NTRK1 P04629 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10088968 0.86 MEN1 (0.42) MAPTMEN1KMT2AKDM4EALDH1A1
SCHEMBL14948915 0.81 PDE2A (0.43) MAPTMEN1KMT2APKMKDM4E
SCHEMBL12017709 0.81 HCRTR1 (0.42) MAPTMEN1KMT2AKDM4EALDH1A1
SCHEMBL12750055 0.79 ALDH1A1 (0.43) MAPTMEN1KMT2APKMKDM4E
SCHEMBL994367 0.78 GAA (0.44) MAPTMEN1KMT2APKMKDM4E
SCHEMBL30517131 0.78 GAA (0.44) MAPTMEN1KMT2APKMKDM4E
SCHEMBL19823249 0.78 MAPT (0.42) MAPTMEN1KMT2AKDM4EALDH1A1
SCHEMBL12015799 0.77 KDM4E (0.39) MAPTMEN1KMT2AKDM4EALDH1A1
SCHEMBL10088426 0.75 NOTUM (0.49) MAPTMEN1KMT2AKDM4EALDH1A1
SCHEMBL31297066 0.75 MAPT (0.53) MAPTMEN1KMT2AKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210052556-A1 SUBSTITUTED THIAZOLO-PYRIDINE COMPOUNDS AS MALT1 INHIBITORS LUPIN LTD (IN) 2021-02-25 US disclosed
US-20190275012-A9 SUBSTITUTED THIAZOLO-PYRIDINE COMPOUNDS AS MALT1 INHIBITORS LUPIN LIMITED (IN) 2019-09-12 US disclosed
US-20190160045-A1 SUBSTITUTED THIAZOLO-PYRIDINE COMPOUNDS AS MALT1 INHIBITORS LUPIN LTD (IN) 2019-05-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210052556-A1 SUBSTITUTED THIAZOLO-PYRIDINE COMPOUNDS AS MALT1 INHIBITORS MALT1, PTP4A1, PTPRO MAPT 2864/4885MEN1 478/4885KMT2A 3418/4885
US-20190275012-A9 SUBSTITUTED THIAZOLO-PYRIDINE COMPOUNDS AS MALT1 INHIBITORS MALT1, PTP4A1, PTPRO MAPT 2864/4885MEN1 478/4885KMT2A 3418/4885
US-20190160045-A1 SUBSTITUTED THIAZOLO-PYRIDINE COMPOUNDS AS MALT1 INHIBITORS MALT1, PTP4A1, PTPRO MAPT 2864/4885MEN1 478/4885KMT2A 3418/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.